{ "tag": [ "compiled" ], "id": "ocds-h6vhtk-029839-2021-03-04T10:27:46Z", "date": "2021-03-04T10:27:46Z", "ocid": "ocds-h6vhtk-029839", "initiationType": "tender", "tender": { "id": "CM/PHG/20/5627", "legalBasis": { "id": "32014L0024", "scheme": "CELEX" }, "title": "NHS National Pharmaceuticals -- Fulvestrant, Darunavir and Imatinib", "status": "complete", "classification": { "scheme": "CPV", "id": "33600000", "description": "Pharmaceutical products" }, "mainProcurementCategory": "goods", "description": "Project title: invitation to offer for NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021.", "lots": [ { "id": "1", "description": "Project title: invitation to offer for NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.", "awardCriteria": { "criteria": [ { "type": "price" } ] }, "hasOptions": true, "options": { "description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement." }, "status": "cancelled" } ], "items": [ { "id": "1", "deliveryAddresses": [ { "region": "UK" } ], "relatedLot": "1" } ], "procurementMethod": "open", "procurementMethodDetails": "Open procedure", "procedure": { "isAccelerated": true, "acceleratedRationale": "This requirement to call for competition came about due to the availability of competitive supply in circumstances relating to intellectual property rights that could not have been foreseen and/or acted upon by the authority using regular tender timescales." }, "techniques": { "hasFrameworkAgreement": true }, "coveredBy": [ "GPA" ] }, "awards": [ { "id": "004316-2021-1", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-7486", "name": "Accord-UK Ltd" } ] }, { "id": "004316-2021-2", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-7487", "name": "Thornton and Ross Ltd" } ] }, { "id": "004316-2021-3", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-7488", "name": "Zentiva Pharma UK Ltd" } ] }, { "id": "004316-2021-4", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-7489", "name": "AstraZeneca" } ] }, { "id": "004316-2021-5", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-7490", "name": "Cipla (EU) Ltd" } ] }, { "id": "004316-2021-6", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-7491", "name": "Dr.Reddy's Laboratories (UK) Limited" } ] }, { "id": "004316-2021-7", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-7492", "name": "Janssen-Cilag Ltd" } ] }, { "id": "004316-2021-8", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-7493", "name": "Sandoz Ltd" } ] }, { "id": "004316-2021-9", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-7494", "name": "Teva UK Limited" } ] }, { "id": "004316-2021-10", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-7495", "name": "Novartis Pharmaceuticals UK Ltd" } ] } ], "parties": [ { "id": "GB-FTS-2505", "name": "The NHS Commissioning Board (operating under the name of NHS England)", "identifier": { "legalName": "The NHS Commissioning Board (operating under the name of NHS England)" }, "address": { "streetAddress": "2nd Floor, Rutland House", "locality": "Runcorn", "region": "UK", "postalCode": "WA7 2ES", "countryName": "United Kingdom" }, "contactPoint": { "email": "gemma.tomlinson1@nhs.net" }, "roles": [ "buyer" ], "details": { "url": "https://www.england.nhs.uk/", "buyerProfile": "https://www.england.nhs.uk/", "classifications": [ { "scheme": "TED_CA_TYPE", "id": "MINISTRY", "description": "Ministry or any other national or federal authority, including their regional or local subdivisions" }, { "scheme": "COFOG", "id": "07", "description": "Health" } ] } }, { "id": "GB-FTS-7486", "name": "Accord-UK Ltd", "identifier": { "legalName": "Accord-UK Ltd" }, "address": { "locality": "Barnstaple", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "large" } }, { "id": "GB-FTS-7487", "name": "Thornton and Ross Ltd", "identifier": { "legalName": "Thornton and Ross Ltd" }, "address": { "locality": "Huddersfield", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "large" } }, { "id": "GB-FTS-7488", "name": "Zentiva Pharma UK Ltd", "identifier": { "legalName": "Zentiva Pharma UK Ltd" }, "address": { "locality": "London", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "large" } }, { "id": "GB-FTS-7489", "name": "AstraZeneca", "identifier": { "legalName": "AstraZeneca" }, "address": { "locality": "Luton", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "large" } }, { "id": "GB-FTS-7490", "name": "Cipla (EU) Ltd", "identifier": { "legalName": "Cipla (EU) Ltd" }, "address": { "locality": "Addlestone", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "sme" } }, { "id": "GB-FTS-7491", "name": "Dr.Reddy's Laboratories (UK) Limited", "identifier": { "legalName": "Dr.Reddy's Laboratories (UK) Limited" }, "address": { "locality": "Beverley", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "sme" } }, { "id": "GB-FTS-7492", "name": "Janssen-Cilag Ltd", "identifier": { "legalName": "Janssen-Cilag Ltd" }, "address": { "locality": "High Wycombe", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "large" } }, { "id": "GB-FTS-7493", "name": "Sandoz Ltd", "identifier": { "legalName": "Sandoz Ltd" }, "address": { "locality": "Camberley", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "sme" } }, { "id": "GB-FTS-7494", "name": "Teva UK Limited", "identifier": { "legalName": "Teva UK Limited" }, "address": { "locality": "Castleford", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "large" } }, { "id": "GB-FTS-7495", "name": "Novartis Pharmaceuticals UK Ltd", "identifier": { "legalName": "Novartis Pharmaceuticals UK Ltd" }, "address": { "locality": "London", "region": "UK", "countryName": "United Kingdom" }, "roles": [ "supplier" ], "details": { "scale": "large" } }, { "id": "GB-FTS-497", "name": "The High Court", "identifier": { "legalName": "The High Court" }, "address": { "streetAddress": "Strand", "locality": "London", "postalCode": "WC2A 2LL", "countryName": "United Kingdom" }, "contactPoint": { "email": "generaloffice@administrativecourtoffice.justice.gov.uk" }, "roles": [ "reviewBody" ], "details": { "url": "https://www.gov.uk/courts-tribunals" } } ], "buyer": { "id": "GB-FTS-2505", "name": "The NHS Commissioning Board (operating under the name of NHS England)" }, "contracts": [ { "id": "004316-2021-1", "awardID": "004316-2021-1", "status": "active", "value": { "amount": 1, "currency": "GBP" }, "dateSigned": "2021-01-15T00:00:00Z" }, { "id": "004316-2021-2", "awardID": "004316-2021-2", "status": "active", "value": { "amount": 1, "currency": "GBP" }, "dateSigned": "2021-01-15T00:00:00Z" }, { "id": "004316-2021-3", "awardID": "004316-2021-3", "status": "active", "value": { "amount": 1, "currency": "GBP" }, "dateSigned": "2021-01-15T00:00:00Z" }, { "id": "004316-2021-4", "awardID": "004316-2021-4", "status": "active", "value": { "amount": 1, "currency": "GBP" }, "dateSigned": "2021-01-15T00:00:00Z" }, { "id": "004316-2021-5", "awardID": "004316-2021-5", "status": "active", "value": { "amount": 1, "currency": "GBP" }, "dateSigned": "2021-01-15T00:00:00Z" }, { "id": "004316-2021-6", "awardID": "004316-2021-6", "status": "active", "value": { "amount": 1, "currency": "GBP" }, "dateSigned": "2021-01-15T00:00:00Z" }, { "id": "004316-2021-7", "awardID": "004316-2021-7", "status": "active", "value": { "amount": 1, "currency": "GBP" }, "dateSigned": "2021-01-15T00:00:00Z" }, { "id": "004316-2021-8", "awardID": "004316-2021-8", "status": "active", "value": { "amount": 1, "currency": "GBP" }, "dateSigned": "2021-01-15T00:00:00Z" }, { "id": "004316-2021-9", "awardID": "004316-2021-9", "status": "active", "value": { "amount": 1, "currency": "GBP" }, "dateSigned": "2021-01-15T00:00:00Z" }, { "id": "004316-2021-10", "awardID": "004316-2021-10", "status": "active", "value": { "amount": 1, "currency": "GBP" }, "dateSigned": "2021-01-15T00:00:00Z" } ], "bids": { "statistics": [ { "id": "1", "measure": "bids", "relatedLot": "1", "value": 16 }, { "id": "4", "measure": "bids", "relatedLot": "1", "value": 16 }, { "id": "7", "measure": "bids", "relatedLot": "1", "value": 16 }, { "id": "10", "measure": "bids", "relatedLot": "1", "value": 16 }, { "id": "13", "measure": "bids", "relatedLot": "1", "value": 16 }, { "id": "16", "measure": "bids", "relatedLot": "1", "value": 16 }, { "id": "19", "measure": "bids", "relatedLot": "1", "value": 16 }, { "id": "22", "measure": "bids", "relatedLot": "1", "value": 16 }, { "id": "25", "measure": "bids", "relatedLot": "1", "value": 16 }, { "id": "28", "measure": "bids", "relatedLot": "1", "value": 16 }, { "id": "2", "measure": "smeBids", "relatedLot": "1", "value": 8 }, { "id": "5", "measure": "smeBids", "relatedLot": "1", "value": 8 }, { "id": "8", "measure": "smeBids", "relatedLot": "1", "value": 8 }, { "id": "11", "measure": "smeBids", "relatedLot": "1", "value": 8 }, { "id": "14", "measure": "smeBids", "relatedLot": "1", "value": 8 }, { "id": "17", "measure": "smeBids", "relatedLot": "1", "value": 8 }, { "id": "20", "measure": "smeBids", "relatedLot": "1", "value": 8 }, { "id": "23", "measure": "smeBids", "relatedLot": "1", "value": 8 }, { "id": "26", "measure": "smeBids", "relatedLot": "1", "value": 8 }, { "id": "29", "measure": "smeBids", "relatedLot": "1", "value": 8 }, { "id": "3", "measure": "electronicBids", "relatedLot": "1", "value": 16 }, { "id": "6", "measure": "electronicBids", "relatedLot": "1", "value": 16 }, { "id": "9", "measure": "electronicBids", "relatedLot": "1", "value": 16 }, { "id": "12", "measure": "electronicBids", "relatedLot": "1", "value": 16 }, { "id": "15", "measure": "electronicBids", "relatedLot": "1", "value": 16 }, { "id": "18", "measure": "electronicBids", "relatedLot": "1", "value": 16 }, { "id": "21", "measure": "electronicBids", "relatedLot": "1", "value": 16 }, { "id": "24", "measure": "electronicBids", "relatedLot": "1", "value": 16 }, { "id": "27", "measure": "electronicBids", "relatedLot": "1", "value": 16 }, { "id": "30", "measure": "electronicBids", "relatedLot": "1", "value": 16 } ] }, "links": [ { "rel": "prev", "href": "https://ted.europa.eu/udl?uri=TED:NOTICE:562997-2020:TEXT:EN:HTML" } ], "language": "en" }